References
Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119:167-72.
McArdle BA, Leung E, Ohira H, et al. The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis. J Nucl Cardiol 2013;20:297-306.
Osborne MT, Hulten EA, Singh A, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol 2014;21:166-74.
Acknowledgement
The authors thank Drs. Lydia Kruge and Meredith Hawkins for their advice and assistance regarding blood sugar management for patient preparation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gonzalez, W.O., Massera, D. & Travin, M.I. False-positive 13N-ammonia/18FDG PET for evaluation of cardiac sarcoidosis in a patient on peritoneal dialysis. J. Nucl. Cardiol. 22, 1323–1325 (2015). https://doi.org/10.1007/s12350-015-0092-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-015-0092-9